Skip to content

AngioSculpt Scoring Balloon Catheter For Bifurcation Coronary Lesions (ABC Study)

AngioSculpt Scoring Balloon Catheter For Bifurcation Coronary Lesions (ABC Study) Prospective, Multi-center, Non-randomized, Single-arm Registry

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00914979
Acronym
ABC
Enrollment
7
Registered
2009-06-05
Start date
2008-09-30
Completion date
2011-09-30
Last updated
2015-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bifurcation Coronary Disease

Keywords

Angiosculpt, Bifurcation Lesion, Side branch, IVUS

Brief summary

Assess the impact of lesion preparation using the AngioSculpt balloon in the treatment of bifurcation lesions in native coronary arteries.

Detailed description

The purpose of the AngioSculpt® Scoring Balloon Catheter For Bifurcation Coronary lesions (ABC registry) is to demonstrate the acute procedural success, device performance and long term outcome associated with use of the AngioSculpt Scoring Balloon Catheter (AngioScore, Inc., Fremont, CA) for lesion preparation in the treatment of bifurcation lesions in native coronary arteries

Interventions

DEVICEAngioSculpt

The AngioSculpt Scoring Balloon Catheter is a standard balloon dilatation catheter with a scoring balloon near the distal tip

Sponsors

HaEmek Medical Center, Israel
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with significant (≥ 50% diameter stenosis) native coronary artery disease involving a bifurcation (Medina class (x,x,1)).

Exclusion criteria

* Concomitant use of Rotablator, Cutting Balloon, or investigational coronary devices. * Additional planned coronary interventions for a non-target lesion within 30 days of the study procedure.

Design outcomes

Primary

MeasureTime frame
Procedural success ≤ 50% diameter stenosis of the main and the side branch at the conclusion of the procedure in the absence of in-hospital MACE9 Months

Secondary

MeasureTime frame
Rate of side branch stenting9 Months
Angiographic dissection rate and grade9 months
MACE rate at 30 days post-procedure9 months
Cumulative stent thrombosis and TLR rates at 9 months9 months

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026